Status:
TERMINATED
The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain
Lead Sponsor:
SPR Therapeutics, Inc.
Conditions:
Neuropathic Pain
Amputation
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves in an individual's amputated leg.This study...
Eligibility Criteria
Inclusion
- Key
- At least 21 years old
- Lower extremity amputation
- Experiencing residual limb (stump) and/or phantom limb pain
- Healed amputation and healthy residual limb based upon the investigator's evaluation
- Key
Exclusion
- Conditions with increased risk of infection (e.g., compromised immune system or history of recurrent skin infections)
- Implanted electronic device
- Pregnancy
Key Trial Info
Start Date :
December 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 22 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03783689
Start Date
December 18 2018
End Date
September 22 2022
Last Update
November 29 2023
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Pain Center of Arizona - Hope Research Institute
Phoenix, Arizona, United States, 85018
2
University of California San Diego
La Jolla, California, United States, 92093
3
Lake Nona Medical Arts
Orlando, Florida, United States, 32827
4
James A. Haley Veterans' Hospital
Tampa, Florida, United States, 33612